To all interested list members.
Recently, through a rather serendipitous
circumstance, we encountered
some encouraging effects from an ancillary protocol involving Human
Growth Hormone (HGH) precursors. We had two groups of volunteers (all
with various stages of macular degeneration) being subjected to
experimental protocols aimed at defining ways of arresting this
condition. One group, for requirements unrelated to the evaluations,
had four members on HGH precursor. These four enjoyed considerably
enhanced improvement----beyond all volunteers. Stimulated by this
phenomenon, we sub-divided group one and initiated a modified protocol
through administering HGH precursors to half (15). Clear advantages
started to appear---in favor of the HGH---within 30 days. We terminated
this evaluation at 40 days and REVERSED the arrangement among this same
population. Allowing for some residual advantage to the ORIGINAL
recipients of HGH, the second group began an improvement cycle similar
to the first group (clearly measureable improvements in blood
circulation, blind-spot expansion control, visible appearance of the
condition of the centra fovea area, reduction of swollen vessels,
etc.). Although there was no restoration of the vision within the
boundaries of the "blind-spot" areas, some of the outer peripheral areas
lightened, considerably----indicating improved circulation (we
believe); and sight-loss areas ceased to expand at rapid rates.
The really encouraging element is that NONE, from among the
four worst cases,
continued to deteriorate after the 15th day of initiation of the HGH
supplementation; showing clear evidence of stabilizing the previous
degenerative accelerations.
While certainly not conclusive, these results are VERY encouraging to
us.
This study is still in progress. I will try to post a
general summary and conclusions upon the completion of this evaluation.
Sincerely. Brooks Bradley.
--
The silver-list is a moderated forum for discussion of colloidal silver.
To join or quit silver-list or silver-digest send an e-mail message to:
[email protected] -or- [email protected]
with the word subscribe or unsubscribe in the SUBJECT line.
To post, address your message to: [email protected]
Silver-list archive: http://escribe.com/health/thesilverlist/index.html
List maintainer: Mike Devour <[email protected]>
